PRA HEALTH SCIENCES INC PRAH

December 12, 2019 - 3:09pm EST by

member

						2019	2020
Price:		102.05		EPS		5.10	5.80
Shares Out. (in M):		66		P/E		20.4	17.9
Market Cap (in $M):		6,684		P/FCF		20	18
Net Debt (in $M):		1,200		EBIT		490	540
TEV (in $M):		7,900		TEV/EBIT		16	14.6

Description

Sign up or Log In

Sign up for free guest access to view investment ideas with a 45-day delay and read the full report.

Log in to read the full report.

show sort by

You are not eligible to view 3 messages. To gain access to more recent message posts signup free for membership.

#	AUTHOR DATE SUBJECT
6	member 3/01/21 8:20PM Re: Author Exit Recommendation 5
ICLR announced the acquisition of PRAH for a 23% premium in a cash-and-shares deal last week. Combined financial guidance of 20%+ growth (after year 1) supports the view that customer demand remains broadly healthy for view available tags
4	member 4/18/20 5:02PM Re: Update 3
Sorry for missing this one. My analyst sent me a response but I forgot to paste it, so here it is, though it's from back in March: The PRAH quarter had pluses and minuses: 1) the clinical segment... login to read the rest view available tags
2	member 12/18/19 1:31PM Re: Quick Questions 1
We haven't spoken to KKR nor know anyone who has, but they've held shares privately since 2013 and publicly since 2014, selling at regular intervals since 2016. If private equity investors expect realized returns within... login to read the rest view available tags

load more messages